UK markets closed

Genmab A/S (GMAB.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
2,084.00-42.00 (-1.98%)
At close: 04:59PM CET
Full screen
Previous close2,126.00
Open2,121.00
Bid2,084.00 x N/A
Ask2,085.00 x N/A
Day's range2,074.00 - 2,131.00
52-week range1,825.00 - 2,947.00
Volume85,923
Avg. volume132,787
Market cap135.838B
Beta (5Y monthly)0.76
PE ratio (TTM)31.55
EPS (TTM)66.06
Earnings date02 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2,667.91
  • Globe Newswire

    Transactions in Connection with Share Buy-back Program

    Company Announcement COPENHAGEN, Denmark; March 25, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares.The share buy-back program is expected to be completed no later than December 16, 2024. The following transactions were executed under the program from March 18, 2024 to March 22, 2024: Trading PlatformNo. of sharesAverage price (DKK)Total value (DKK) March 18, 2024XCSE7,7532,051.78

  • Globe Newswire

    Completion of share buy-back program

    Company Announcement COPENHAGEN, Denmark; March 18, 2024 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on March 15, 2024 On February 14, 2024, Genmab announced the initiation of a share buy-back program to honor our commitments under our Restricted Stock Units program. The share buy-back program was expected to be completed no later than March 15, 2024, and comprised up to 190,000 shares. The following transactions were executed under the program from M

  • Insider Monkey

    30 Biggest Biotechnology Companies in the World

    In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]